Depreciation of IMMUCELL CORP /DE/ from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
IMMUCELL CORP /DE/ quarterly and annual Depreciation in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • IMMUCELL CORP /DE/ Depreciation for the quarter ending 30 Sep 2025 was $674,314, a 0.59% increase year-over-year.
  • IMMUCELL CORP /DE/ Depreciation for the twelve months ending 30 Sep 2025 was $2,678,032, a 0.33% increase year-over-year.
  • IMMUCELL CORP /DE/ annual Depreciation for 2024 was $2,668,077, a 1.1% decline from 2023.
  • IMMUCELL CORP /DE/ annual Depreciation for 2023 was $2,697,897, a 9.3% increase from 2022.
  • IMMUCELL CORP /DE/ annual Depreciation for 2022 was $2,468,479, a 1.1% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

IMMUCELL CORP /DE/ Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,678,032 $674,314 +$3,968 +0.59% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $2,674,064 $663,455 -$2,727 -0.41% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $2,676,791 $671,191 +$8,714 +1.3% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $2,668,077 $669,072 -$1,037 -0.16% 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q3 2024 $2,669,114 $670,346 -$25,289 -3.6% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $2,694,403 $666,182 -$13,837 -2% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $2,708,240 $662,477 +$10,343 +1.6% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $2,697,897 $670,109 +$70,630 +12% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $2,627,267 $695,635 +$68,091 +11% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $2,559,176 $680,019 +$55,410 +8.9% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $2,503,766 $652,134 +$35,287 +5.7% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $2,468,479 $599,479 +$3,054 +0.51% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $2,465,425 $627,544 +$14,155 +2.3% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $2,451,270 $624,609 +$7,082 +1.1% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $2,444,188 $616,847 +$2,152 +0.35% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $2,442,036 $596,425 -$12,361 -2% 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $2,454,397 $613,389 +$17,379 +2.9% 01 Jul 2021 30 Sep 2021 10-Q 21 Nov 2022 2022 Q3
Q2 2021 $2,437,018 $617,527 +$49,268 +8.7% 01 Apr 2021 30 Jun 2021 10-Q/A 21 Nov 2022 2022 Q2
Q1 2021 $2,387,750 $614,695 +$59,571 +11% 01 Jan 2021 31 Mar 2021 10-Q/A 21 Nov 2022 2022 Q1
Q4 2020 $2,328,179 $608,786 +$51,518 +9.2% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $2,276,661 $596,010 +$33,288 +5.9% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $2,243,373 $568,259 +$3,737 +0.66% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $2,239,636 $555,124 -$8,681 -1.5% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $2,248,317 $557,268 -$5,923 -1.1% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 $2,254,240 $562,722 +$184,894 +49% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $2,069,346 $564,522 +$283,830 +101% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q1 2019 $1,785,516 $563,805 +$283,909 +101% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q4 2018 $1,501,607 $563,191 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 $377,828 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $280,692 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019 2019 Q2
Q1 2018 $279,896 +$66,430 +31% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q1 2017 $213,466 +$50,919 +31% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q1 2016 $162,547 +$46,883 +41% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q1 2015 $115,664 +$3,302 +2.9% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016 2016 Q1
Q1 2014 $112,362 +$15,239 +16% 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015 2015 Q1
Q1 2013 $97,123 -$6,090 -5.9% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q1
Q1 2012 $103,213 -$1,944 -1.8% 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q1 2011 $105,157 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012 2012 Q1

IMMUCELL CORP /DE/ Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,668,077 -$29,820 -1.1% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $2,697,897 +$229,418 +9.3% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $2,468,479 +$26,443 +1.1% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $2,442,036 +$113,857 +4.9% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $2,328,179 +$79,862 +3.6% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $2,248,317 +$746,710 +50% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $1,501,607 +$616,276 +70% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
2017 $885,331 +$102,056 +13% 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
2016 $783,275 +$257,357 +49% 01 Jan 2016 31 Dec 2016 10-K 29 Mar 2018 2017 FY
2015 $525,918 +$79,873 +18% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2014 $446,045 +$31,738 +7.7% 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
2013 $414,307 +$14,667 +3.7% 01 Jan 2013 31 Dec 2013 10-K 25 Mar 2016 2015 FY
2012 $399,640 -$13,492 -3.3% 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY
2011 $413,132 -$3,786 -0.91% 01 Jan 2011 31 Dec 2011 10-K 26 Mar 2014 2013 FY
2010 $416,918 01 Jan 2010 31 Dec 2010 10-K 28 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.